Commercialization: Launch, Promotion, Distribution, Pricing and Reimbursement

Transitioning from discovery research through clinical development to product launch is a challenging process. Companies need to have the right approach and plan, as well as the right personnel and other resources, in the right place at the right time. But what resources and information at what time?

A panel of experts will explore the commercialization process, focusing on understanding and quantifying market opportunities; developing a product profile; addressing needs of key stakeholders such as patients, prescribing physicians, third party payers; building your health economic story through channels such as patient advocacy and academic and medical publications; pricing and reimbursement issues; and more.

A panel of experts will explore the commercialization process, focusing on:

* Understanding and quantifying market opportunities
* Developing a product profile
* Addressing the needs of key stakeholders, such as patients, prescribing physicians, and third party payers
* Conveying your company's messages through channels such as patient advocacy as well as academic and medical publications
* Pricing and reimbursement issues
* Distribution
* And more

Moderator:

Jennifer Miller, partner, Ballard Spahr Andrews & Ingersoll, LLP

Panelists:

* Chris Cashman, president & CEO, Protez Pharmaceuticals, Inc.
* Robert Glasgow, senior vice president, commercial solutions, AmerisourceBergen Specialty Group
* Cheryl Kramer, global marketing leader, immunology, Johnson & Johnson
* Jerry McLaughlin, vice president, commercial operations, NuPathe Inc.

Registration:

3:45 p.m. - 4:15 p.m.

Program:

4:15 p.m. - 5:30 p.m.

Networking Reception:

5:30 p.m. - 6:30 p.m.

• Advertising
• Life Sciences
• Marketing
• Sales